ASX - By Stock
|
XJO |
Re:
Indices 15/07
|
|
Esmer
|
25 |
3.2K |
6 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
25
|
3.2K
|
6
|
|
ASX - By Stock
|
XJO |
Re:
Bull Market posts, posts that support the Bull Case
|
|
Esmer
|
989 |
189K |
2 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
989
|
189K
|
2
|
|
ASX - By Stock
|
IRE |
Re:
please dont stuff up webiress!!
|
|
Esmer
|
86 |
20K |
1 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
86
|
20K
|
1
|
|
ASX - By Stock
|
IRE |
Re:
please dont stuff up webiress!!
|
|
Esmer
|
86 |
20K |
1 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
86
|
20K
|
1
|
|
ASX - By Stock
|
XJO |
Re:
Indices 08/07
|
|
Esmer
|
70 |
10K |
6 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
70
|
10K
|
6
|
|
ASX - By Stock
|
XJO |
Re:
Indices 08/07
|
|
Esmer
|
70 |
10K |
4 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
70
|
10K
|
4
|
|
ASX - By Stock
|
IRE |
Re:
please dont stuff up webiress!!
|
|
Esmer
|
86 |
20K |
4 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
86
|
20K
|
4
|
|
ASX - By Stock
|
IRE |
Re:
please dont stuff up webiress!!
|
|
Esmer
|
86 |
20K |
2 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
86
|
20K
|
2
|
|
ASX - By Stock
|
XJO |
Re:
Indices 01/07
|
|
Esmer
|
27 |
4.7K |
6 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
27
|
4.7K
|
6
|
|
ASX - General
|
|
Re:
IRESS Viewpoint
|
|
Esmer
|
158 |
25K |
1 |
05/07/24 |
05/07/24 |
ASX - General
|
158
|
25K
|
1
|
|
ASX - By Stock
|
IRE |
Re:
IRE.AX - 1-year return: -20.9% / The worst-returning ASX 200 stocks of FY24 (across each sector)
|
|
Esmer
|
4 |
1.0K |
3 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
4
|
1.0K
|
3
|
|
ASX - General
|
|
Re:
IRESS Viewpoint
|
|
Esmer
|
158 |
25K |
5 |
05/07/24 |
05/07/24 |
ASX - General
|
158
|
25K
|
5
|
|
ASX - General
|
|
Re:
IRESS Viewpoint
|
|
Esmer
|
158 |
25K |
3 |
03/07/24 |
03/07/24 |
ASX - General
|
158
|
25K
|
3
|
|
ASX - By Stock
|
IRE |
Re:
please dont stuff up webiress!!
|
|
Esmer
|
86 |
20K |
2 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
86
|
20K
|
2
|
|
ASX - General
|
|
Re:
IRESS Viewpoint
|
|
Esmer
|
158 |
25K |
3 |
02/07/24 |
02/07/24 |
ASX - General
|
158
|
25K
|
3
|
|
ASX - By Stock
|
XJO |
Re:
Indices 01/07
|
|
Esmer
|
27 |
4.7K |
1 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
27
|
4.7K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in substantial holding
|
|
Esmer
|
15 |
3.4K |
0 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
15
|
3.4K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Multibagger (10x)
|
|
Esmer
|
36 |
9.2K |
2 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
36
|
9.2K
|
2
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
Esmer
|
16K |
2.8M |
2 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
16K
|
2.8M
|
2
|
|
ASX - By Stock
|
LSF Managed Funds |
Re:
Charts
|
|
Esmer
|
27 |
11K |
0 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
27
|
11K
|
0
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
Esmer
|
16K |
2.8M |
7 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
16K
|
2.8M
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Slow death
|
|
Esmer
|
39 |
9.3K |
8 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
39
|
9.3K
|
8
|
|
ASX - By Stock
|
XJO |
Re:
Indices 10/06
|
|
Esmer
|
21 |
3.6K |
1 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
21
|
3.6K
|
1
|
|
ASX - By Stock
|
LSF |
Re:
Ann: On-market share buy back
|
|
Esmer
|
21 |
6.4K |
3 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
21
|
6.4K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma Business Update
|
|
Esmer
|
17 |
5.5K |
6 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
17
|
5.5K
|
6
|
|
ASX - By Stock
|
LSF |
Re:
Ann: On-market share buy back
|
|
Esmer
|
21 |
6.4K |
0 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
21
|
6.4K
|
0
|
|
ASX - By Stock
|
HM1 |
Re:
Ann: April Investment Update
|
|
Esmer
|
10 |
3.2K |
1 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
10
|
3.2K
|
1
|
|
ASX - By Stock
|
XJO |
Re:
06/05 Indices
|
|
Esmer
|
49 |
8.0K |
5 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
49
|
8.0K
|
5
|
|
ASX - By Stock
|
XJO |
Re:
Indices 29/4
|
|
Esmer
|
43 |
7.5K |
15 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
43
|
7.5K
|
15
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
Esmer
|
16K |
2.8M |
6 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
16K
|
2.8M
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
Esmer
|
22 |
4.7K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
22
|
4.7K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
Esmer
|
22 |
4.7K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
22
|
4.7K
|
0
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
Esmer
|
16K |
2.8M |
8 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
16K
|
2.8M
|
8
|
|
ASX - By Stock
|
LSF |
Re:
Ann: Net Tangible Asset Backing
|
|
Esmer
|
4 |
1.6K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
4
|
1.6K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Esmer
|
161 |
34K |
7 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
161
|
34K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Esmer
|
161 |
34K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
161
|
34K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Esmer
|
161 |
34K |
2 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
161
|
34K
|
2
|
|
ASX - By Stock
|
LSF |
Re:
Ann: Joint MD - Medical Leave
|
|
Esmer
|
4 |
1.5K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
4
|
1.5K
|
0
|
|
ASX - By Stock
|
LSF |
Re:
Ann: Net Tangible Asset Backing
|
|
Esmer
|
5 |
1.8K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5
|
1.8K
|
3
|
|
ASX - By Stock
|
XJO |
Re:
Indices 01/04
|
|
Esmer
|
101 |
17K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
101
|
17K
|
3
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
Esmer
|
16K |
2.8M |
8 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
16K
|
2.8M
|
8
|
|
ASX - By Stock
|
XJO |
Re:
Indices 4/3
|
|
Esmer
|
77 |
13K |
5 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
77
|
13K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Has the seling dried up
|
|
Esmer
|
72 |
14K |
3 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
72
|
14K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV US FDA Appeal Outcome
|
|
Esmer
|
60 |
14K |
3 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
60
|
14K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Has the seling dried up
|
|
Esmer
|
72 |
14K |
3 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
72
|
14K
|
3
|
|
ASX - By Stock
|
XJO |
Re:
12/02 Indices
|
|
Esmer
|
146 |
21K |
8 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
146
|
21K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Capital raising this Quarter ?
|
|
Esmer
|
15 |
3.6K |
6 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
15
|
3.6K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Capital raising this Quarter ?
|
|
Esmer
|
15 |
3.6K |
1 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
15
|
3.6K
|
1
|
|
ASX - By Stock
|
XJO |
Re:
29/01 Indices
|
|
Esmer
|
145 |
20K |
5 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
145
|
20K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Viraleze shows antiviral efficacy in COVID-19 patients
|
|
Esmer
|
74 |
15K |
3 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
74
|
15K
|
3
|
|